Peripheral Neurectomy for Management of Trigeminal Neuralgia Refractory to Multiple Surgical Procedures.
Journal
Plastic and reconstructive surgery. Global open
ISSN: 2169-7574
Titre abrégé: Plast Reconstr Surg Glob Open
Pays: United States
ID NLM: 101622231
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
04
06
2020
accepted:
29
09
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
epublish
Résumé
Trigeminal Neuralgia (TN) is defined as a recurrent, unilateral, brief, electric shock-like pain and is associated with a significant deterioration in quality of life due to the debilitating nature of the pain. The first line treatment is medical therapy, and surgical treatment is reserved for patients with inadequate pain control or undesirable side effects. Surgical options for treatment may include microvascular decompression (MVD), stereotactic radiosurgery, percutaneous radiofrequency rhizotomy, and percutaneous balloon compression of trigeminal ganglion. MVD is considered the procedure of choice due to its high efficacy and safety profile; however, it carries a recurrence rate of 1%-5% annually and 15%-35% long term. Although re-operative MVD has been reported for recurrent cases, it carries a high risk of complications due to arachnoid adhesions and distorted anatomy. Peripheral neurectomy is a simple, expeditious, low-risk procedure that is well tolerated by patients and can be done even under local anesthesia. We report a case of a 69-year-old man who presented with a debilitating TN in the V1 and V2 territory refractory to MVD, stereotactic radiosurgery, and percutaneous balloon compression of the trigeminal ganglion, who had been treated with neurectomy of the left supraorbital, supratrochlear, and infraorbital nerves, with an excellent outcome at 6 months follow-up. Peripheral neurectomy is an effective alternative for patients with refractory TN who failed multiple surgical interventions. Previous publications have reported an elevated long-term recurrence rate after this procedure, perhaps due to peripheral nerve regeneration or neuroma formation. It is not yet studied whether using nerve conduits may lead to a decrease in recurrence.
Identifiants
pubmed: 33299723
doi: 10.1097/GOX.0000000000003264
pmc: PMC7722546
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e3264Informations de copyright
Copyright © 2020 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.
Références
World Neurosurg. 2019 Dec;132:154-160
pubmed: 31493610
J Neurosci Rural Pract. 2012 May;3(2):152-7
pubmed: 22865967
J Neurosurg. 2018 Apr 27;130(3):733-757
pubmed: 29701555
Eur J Pain. 2020 Feb;24(2):338-345
pubmed: 31571339
J Maxillofac Oral Surg. 2019 Mar;18(1):15-22
pubmed: 30728686
Acta Neurochir (Wien). 2011 May;153(5):1043-50
pubmed: 21409517
World Neurosurg. 2018 Aug;116:e86-e91
pubmed: 29807177
J Maxillofac Oral Surg. 2014 Sep;13(3):295-9
pubmed: 25018603
World Neurosurg. 2018 Feb;110:e593-e598
pubmed: 29175572
J Maxillofac Oral Surg. 2011 Sep;10(3):195-8
pubmed: 22942586